CNCure biotech Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Latest Deal Amount
-
$4.59M
- Investors
-
9
CNCure biotech General Information
Description
Operator of a biotechnology company intended to provide expertise in drug development and cancer therapeutics. The company's offerings comprise an innovative microbial platform for cancer therapy, molecular imaging spies for making informed decisions, and a radio-theranostics platform for simultaneous diagnosis and treatment of diseases, providing healthcare professionals with science and technology that can diagnose diseases early and treat them to improve health conditions.
Contact Information
Website
www.cncure.co.krCorporate Office
- National Immunotherapy Innovation Center, Suite 303
- 264 Seoyang-ro, Hwasun-eup, Hwasun-gun
- Hwaseong, Jeollanam 58128
- South Korea
Corporate Office
- National Immunotherapy Innovation Center, Suite 303
- 264 Seoyang-ro, Hwasun-eup, Hwasun-gun
- Hwaseong, Jeollanam 58128
- South Korea
CNCure biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 25-Jun-2026 | $4.59M | In Progress | Clinical Trials - Phase 1 | ||
| 5. Accelerator/Incubator | 14-Aug-2024 | Completed | Clinical Trials - Phase 1 | |||
| 4. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 3. Early Stage VC (Series B) | 13-Jun-2022 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC (Series A) | 01-Feb-2021 | $6M | $8M | Completed | Clinical Trials - Phase 1 | |
| 1. Seed Round | 01-Dec-2019 | $2M | $2M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CNCure biotech Patents
CNCure biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025100987-A1 | Dna construct for expressing signaling substance for cancer treatment, and cancer treatment method using same | Inactive | 09-Nov-2023 | ||
| AU-2022382621-A1 | Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer | Pending | 05-Nov-2021 | ||
| CA-3236831-A1 | Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer | Pending | 05-Nov-2021 | ||
| EP-4427755-A1 | Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer | Pending | 05-Nov-2021 | ||
| EP-4427755-A4 | Pharmaceutical composition comprising salmonella strain and immune checkpoint inhibitor as active ingredient for prevention or treatment of cancer | Pending | 05-Nov-2021 | A61K35/74 |
CNCure biotech Signals
CNCure biotech Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | |||
| Hana Ventures | Corporate Venture Capital | Minority | ||
| ID Ventures (South Korea) | Venture Capital | Minority | ||
| Colopl Next | Corporate Venture Capital | Minority | ||
| DTN Investment (VC) | Venture Capital | Minority |
CNCure biotech FAQs
-
When was CNCure biotech founded?
CNCure biotech was founded in 2019.
-
Where is CNCure biotech headquartered?
CNCure biotech is headquartered in Hwaseong, South Korea.
-
What is the size of CNCure biotech?
CNCure biotech has 15 total employees.
-
What industry is CNCure biotech in?
CNCure biotech’s primary industry is Drug Discovery.
-
Is CNCure biotech a private or public company?
CNCure biotech is a Private company.
-
What is CNCure biotech’s current revenue?
The current revenue for CNCure biotech is .
-
How much funding has CNCure biotech raised over time?
CNCure biotech has raised $12M.
-
Who are CNCure biotech’s investors?
Johnson & Johnson Innovation - JLABS, Hana Ventures, ID Ventures (South Korea), Colopl Next, and DTN Investment (VC) are 5 of 9 investors who have invested in CNCure biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process